» Articles » PMID: 36434160

Nutrient-sensing MTORC1 and AMPK Pathways in Chronic Kidney Diseases

Overview
Journal Nat Rev Nephrol
Specialty Nephrology
Date 2022 Nov 26
PMID 36434160
Authors
Affiliations
Soon will be listed here.
Abstract

Nutrients such as glucose, amino acids and lipids are fundamental sources for the maintenance of essential cellular processes and homeostasis in all organisms. The nutrient-sensing kinases mechanistic target of rapamycin (mTOR) and AMP-activated protein kinase (AMPK) are expressed in many cell types and have key roles in the control of cell growth, proliferation, differentiation, metabolism and survival, ultimately contributing to the physiological development and functions of various organs, including the kidney. Dysregulation of these kinases leads to many human health problems, including cancer, neurodegenerative diseases, metabolic disorders and kidney diseases. In the kidney, physiological levels of mTOR and AMPK activity are required to support kidney cell growth and differentiation and to maintain kidney cell integrity and normal nephron function, including transport of electrolytes, water and glucose. mTOR forms two functional multi-protein kinase complexes, mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). Hyperactivation of mTORC1 leads to podocyte and tubular cell dysfunction and vulnerability to injury, thereby contributing to the development of chronic kidney diseases, including diabetic kidney disease, obesity-related kidney disease and polycystic kidney disease. Emerging evidence suggests that targeting mTOR and/or AMPK could be an effective therapeutic approach to controlling or preventing these diseases.

Citing Articles

sPLA2-IB and PLA2R Mediate Aberrant Glucose Metabolism in Podocytes via Hyperactivation of the mTOR/HIF-1α Pathway.

Bao J, Dai B, Yang L, Liu Z, Jin Y, Zhao H Cell Biochem Biophys. 2025; .

PMID: 40072831 DOI: 10.1007/s12013-025-01714-5.


Redox regulation: mechanisms, biology and therapeutic targets in diseases.

Li B, Ming H, Qin S, Nice E, Dong J, Du Z Signal Transduct Target Ther. 2025; 10(1):72.

PMID: 40050273 PMC: 11885647. DOI: 10.1038/s41392-024-02095-6.


Trehalose activates autophagy to alleviate cisplatin-induced chronic kidney injury by targeting the mTOR-dependent TFEB signaling pathway.

Yang J, Yuan L, Li L, Liu F, Liu J, Chen Y Theranostics. 2025; 15(6):2544-2563.

PMID: 39990216 PMC: 11840734. DOI: 10.7150/thno.102559.


Sodium glucose co-transporter 2 inhibitors (SGLT2i) for pediatric kidney disease: the future is near.

Portalatin G, Hong-McAtee I, Burgner A, Gould E, Hunley T Front Pediatr. 2025; 13:1521425.

PMID: 39950157 PMC: 11821607. DOI: 10.3389/fped.2025.1521425.


Low Temperature Plasma Jet Treatment Promotes Skin Wound Healing by Enhancing Cell Proliferation via the PI3K-AKT and AMPK Pathways.

Zhu Y, Lian X, Li K, Zhang J, Wu W, Zhang X Int Wound J. 2025; 22(2):e70213.

PMID: 39934939 PMC: 11813701. DOI: 10.1111/iwj.70213.